STAT3 cyclic oligonucleotide decoy-a new therapeutic avenue for NSCLC?
Transl Lung Cancer Res
.
2018 Dec;7(Suppl 4):S381-S384.
doi: 10.21037/tlcr.2018.09.14.
Authors
Lennard Y W Lee
1
,
Summaya Mohammad
1
,
Thomas Starkey
1
,
Siow-Ming Lee
2
3
Affiliations
1
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
2
Department of Oncology, University College London Hospitals, London, UK.
3
Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
PMID:
30705862
PMCID:
PMC6328701
DOI:
10.21037/tlcr.2018.09.14
No abstract available
Publication types
Editorial
Comment